Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
Hemiplegia
Antimicrobial proteins with homology to serine proteases.
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer. Cureus. 2021 Jul; 13(7):e16266.
View in:
PubMed
authors with profiles
Ravi Salgia